Evidence Reports For MCAC Incontinence Panel Raise Stakeholder Concerns
This article was originally published in The Gray Sheet
Executive Summary
Members of the Medicare Coverage Advisory Committee's Medical and Surgical Procedures Panel, set to review urinary incontinence treatments April 12-13, have access upon request to any data or correspondence submitted by outside stakeholders to the Health Care Financing Administration, agency officials report.
You may also be interested in...
Small Controlled Trials Inadequate For Incontinence Device MCAC Review
Five randomized controlled trials comparing the effectiveness of pelvic floor electrical stimulation (PFES) to a sham device for stress incontinence treatment are "inadequate" evidence by which to judge effectiveness, the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee concluded at its April 13 meeting.
Small Controlled Trials Inadequate For Incontinence Device MCAC Review
Five randomized controlled trials comparing the effectiveness of pelvic floor electrical stimulation (PFES) to a sham device for stress incontinence treatment are "inadequate" evidence by which to judge effectiveness, the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee concluded at its April 13 meeting.
Instructions To MCAC Panels Will Not Lead To Coverage Delays, HCFA Says
Preparation of an evidence report prior to a coverage review by a Medicare Coverage Advisory Committee panel will not add significant delays to the coverage process established by the Health Care Financing Administration, HCFA officials contend.